Multiple Sclerosis
Conference Coverage
Influenza vaccine efficacy called undiminished in MS
Meta-analysis results are consistent with latest AAN immunization guideline.
MS Briefs
Rituximab safe and effective in pregnant women with MS
MS Briefs
MS tied to higher risk of vascular disease and mortality
MS Briefs
Relapsing-remitting MS: Relapse rates with oral therapies
MS Briefs
MS: Correlation between muscle strength and walking performance
Conference Coverage
CMSC MRI guidelines evolve into international consensus protocol
Internationally accepted consensus guidelines will improve lagging conformity with the recommendations.
Literature Review
Relapsing, progressive MS classifications should be abandoned
“The disease appears to be more of a continuum of disability progression, which is sometimes also accompanied by relapses.”
News
FDA approves Uplizna for treatment of anti-AQP4 antibody–positive NMOSD
Second FDA-approved therapy for neuromyelitis optica spectrum disorder offers patients additional treatment option.
Conference Coverage
Cannabis misconceptions still common among MS clinicians
Studies and surveys underscore that misconceptions about cannabis could be common among clinicians and patients.
Conference Coverage
Function in MS may vary significantly within EDSS scores
Mean normalized velocity of preferred walking speed may vary by more than 20% within EDSS groups and overlap by more than 20% between groups.